Ranitidine HCI is an H-2 receptor antagonista for the treatment of peptic gastric secretion with small biovailability, so that should be developed in a sustained release dosage form are retained in the stomach. Ranitidine HCl floating tablet was formulation by effervescent system. Simplex lattice design was applied to optimize the formula of ranitidine HCl floating tablet by varying levels of …